ADUS - Addus HomeCare Corporation
| Previous Close | 93.84 |
| Open | 94.15 |
| Bid | 95.23 x 800 |
| Ask | 95.44 x 900 |
| Day's Range | 94.15 - 95.63 |
| 52 Week Range | 73.66 - 114.99 |
| Volume | |
| Avg. Volume | 156,011 |
| Market Cap | 1.537B |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 30.50 |
| EPS (TTM) | 3.11 |
| Earnings Date | Jul 31, 2023 - Aug 04, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 113.86 |
ZacksThermo Fisher's (TMO) Unveils Orbitrap Astral Spectrometer
Thermo Fisher's (TMO) OrbitrapTM AstralTM mass spectrometer enables accurate and exact quantification in proteomics laboratories.
ZacksHologic (HOLX) Stock Up 5.6% YTD: Will the Rally Continue?
The higher capital equipment revenues, procedural volumes return and an acceleration from the new business lines poise Hologic (HOLX) for future growth.
ZacksHere's Why You Should Hold on to Align Technology (ALGN) Now
Investors are optimistic about Align Technology (ALGN) owing to expanding work-flow options of its leading iTero scanners.
ZacksADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
ZacksIllumina's (ILMN) New AI Tool to Predict Genomics Disease
Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.
ZacksHaemonetics (HAE) Hospital Arm Grows, Plasma Volume Improves
Within Haemonetics (HAE) Vascular Closure, growth is led by the opening of new accounts and increasing penetration to gain share in the top U.S. EP hospitals.
- Zacks
Charles River (CRL) to Build RightSource Lab With New Pact
Charles River (CRL) will establish a CGMP testing lab at Wheeler's factory through latest partnership.
ZacksBio-Rad (BIO) Faces Macroeconomic Headwinds, Rising Expenses
Bio-Rad's (BIO) process chromatography business witnesses a slowdown in the quarter due to tough comparisons and some softness in the bioprocessing market.
- Zacks
Boston Scientific (BSX) Rises 26.4%: Will the Rally Continue?
Boston Scientific (BSX) gains from strong improvement in organic sales, indicating a solid rebound in the legacy business.
ZacksWall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should Know
The mean of analysts' price targets for Addus HomeCare (ADUS) points to a 28.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ZacksMedtronic (MDT) to Expand Diabetes Care With New Buyout
Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.
ZacksHere's Why You Should Retain CVS Health (CVS) Stock for Now
Investors are optimistic about CVS Health (CVS) on continued growth across the entire range of insured and self-insured medical, pharmacy, dental and behavioral health products and services.
Simply Wall St.Investors in Addus HomeCare (NASDAQ:ADUS) have seen favorable returns of 54% over the past five years
Addus HomeCare Corporation ( NASDAQ:ADUS ) shareholders might be concerned after seeing the share price drop 22% in the...
ZacksThermo Fisher (TMO) Expands Manufacturing Facility in APAC
Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.
Business WireAddus HomeCare to Participate in the 2023 Jefferies Healthcare Conference
FRISCO, Texas, May 24, 2023--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the 2023 Jefferies Healthcare Conference, which takes place June 7-9, 2023, in New York City.
- Zacks
Here's Why Investors Should Add Zimmer Biomet (ZBH) Now
Investors are optimistic about Zimmer Biomet (ZBH) on continued procedure recovery, solid execution and increasing traction around innovations.
- Zacks
QIAGEN (QGEN) Expands Enzyme Offering to Aid Laboratory
QIAGEN is a one-stop shop for all research needs, including solutions for sample preparation, automation and bioinformatics with enzyme offering expansion.
ZacksAbbott (ABT) Expands in Electrophysiology With New FDA Nod
Abbott (ABT) notes that using TactiFlex catheter can lead to reduced procedure times and better safety compared to the company's previous generation catheters.
ZacksHologic (HOLX) Gets FDA Nod for Multiplexed Respiratory Test
Hologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.
ZacksAbbott's (ABT) Assert-IQ Cardiac Monitor Receives FDA Approval
Abbott's (ABT) latest approval adds to its line-up of remote patient management and treatment tools that can support doctors more effectively.
- Zacks
STERIS (STE) Continues to Face Dull Dental Sales, Margin Woes
STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.
ZacksEdwards Lifesciences' (EW) TAVR Study Outcome Favorable
Edwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe.
ZacksHere's Why Investors Should Retain Omnicell (OMCL) Stock Now
Investors are optimistic about Omnicell (OMCL) on its strong execution of strategies, disciplined cost management and revenue timing.
ZacksADUS vs. USPH: Which Stock Is the Better Value Option?
ADUS vs. USPH: Which Stock Is the Better Value Option?
ZacksMedtronic's (MDT) Global Market Share Strong, FX Headwind Stays
Within cardiac rhythm management, Medtronic's (MDT) pacing business continues to outperform the market, banking on strong global growth of its Micra leadless pacemaker family.
